Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results, Beats Estimates By $0.01 EPS

Alpha Teknova (NASDAQ:TKNO) released its quarterly earnings data on Wednesday. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01, FiscalAI reports. Alpha Teknova had a negative return on equity of 23.32% and a negative net margin of 42.59%.The firm had revenue of $11.08 million for the quarter, compared to the consensus estimate of $10.23 million.

Alpha Teknova Stock Down 2.7%

NASDAQ:TKNO traded down $0.10 during trading hours on Wednesday, reaching $3.64. 120,394 shares of the stock were exchanged, compared to its average volume of 195,348. Alpha Teknova has a twelve month low of $1.91 and a twelve month high of $7.48. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.58 and a quick ratio of 3.64. The firm has a 50 day moving average of $2.81 and a 200 day moving average of $3.60. The stock has a market cap of $195.14 million, a PE ratio of -11.03 and a beta of 0.47.

Insiders Place Their Bets

In related news, CEO Stephen Gunstream acquired 26,000 shares of the company’s stock in a transaction dated Friday, March 6th. The shares were bought at an average price of $2.15 per share, for a total transaction of $55,900.00. Following the purchase, the chief executive officer directly owned 269,497 shares in the company, valued at approximately $579,418.55. This trade represents a 10.68% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 12.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Alpha Teknova

A number of large investors have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Alpha Teknova during the 2nd quarter worth $29,000. JPMorgan Chase & Co. boosted its stake in Alpha Teknova by 123.1% in the second quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock valued at $40,000 after buying an additional 4,504 shares in the last quarter. Larson Financial Group LLC boosted its stake in Alpha Teknova by 58.5% in the third quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after buying an additional 3,464 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Alpha Teknova during the fourth quarter valued at about $77,000. Finally, Sherbrooke Park Advisers LLC acquired a new stake in shares of Alpha Teknova during the third quarter valued at about $94,000. Institutional investors own 13.81% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Alpha Teknova in a research note on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $8.00.

Alpha Teknova Company Profile

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.